General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0KRSBQ
ADC Name
IKS-012
Synonyms
IKS 012; IKS012
   Click to Show/Hide
Organization
Iksuda Therapeutics Ltd.
Drug Status
Clinical candidate
Indication
In total 3 Indication(s)
Lung cancer [ICD11:2C25]
Clinical candidate
Ovarian cancer [ICD11:2C73]
Clinical candidate
Triple negative breast cancer [ICD11:2C60-2C65]
Clinical candidate
Antibody Name
Undisclosed
Antigen Name
Folate receptor alpha (FOLR1)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.